High levels of NKAP have been observed in most tumor types (https://www.proteinatlas.org/ENSG00000101882-NKAP/pathology), and it has been described as an oncogene in hepatocellular carcinoma [141], glioma [142], and breast cancer [143], even as an unfavorable prognostic indicator in the latter (https://www.proteinatlas.org/ENSG00000101882-NKAP/pathology/tissue/breast+cancer). Here, NKAP is linked to breast carcinoma.